Skip to content

13F-HR filed by PATHWAY CAPITAL MANAGEMENT, LP

PATHWAY CAPITAL MANAGEMENT, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-10, with 6 holding rows worth $56,034,081.

Accession
0001214659-23-001894
Filed
2023-02-10
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A holdings report, 6 entries on the cover page, a total value of $56,034,081 stated on the cover page (in dollars after the unit check, H1), rows summing to $56,034,081 with VALUE read as dollars as filed, 13F file number 028-19862. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Day One Biopharmaceuticals Inc23954D109Common Stock995,686$21,427,163dollars as filed
TOASTINCCLASSCLASSA888787108STOK1,168,871$21,074,744dollars as filed
ARCELLX INC COMMON STOCK03940C100Stock189,120$5,858,938dollars as filed
AVEO PHARMACEUTICALS INC053588307COM245,606$3,671,810dollars as filed
TRANSDIGM GROUP INC COM893641100Stock4,530$2,852,315dollars as filed
FLYWIRE CORPORATION302492103COM VTG46,960$1,149,111dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001214659-23-001894this filing2023-02-10acceptance time not in the bulk data set